NCT00189228View on ClinicalTrials.gov

Immune Dysfunction in Allergic Asthma

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Asthma
Interventions
DRUG

Xolair

Patients are administered Xolair

Trial Locations (1)

87131

UNM HSC, Albuquerque

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of New Mexico

OTHER

NCT00189228 - Immune Dysfunction in Allergic Asthma | Biotech Hunter | Biotech Hunter